Unifarm pharmaceutical company as an independent company, that exists since the beginning of 2003. The main activity of the company is import,export and distribution of medicines and medical materials-wholesale, and represntation of producers of medicines and medical materials. Although we exist for a short period of time we managed to occupy an enviable place in Bosnia and Herzegovina.
On this success, we have to thank first of all on the experience of our employees, and the successful cooperation with well-known pharmaceutical companies in the country and abroad.
The company employs 64 workers with rich experience in the transport and distribution of drugs at wholesale and retail.
The company has its own office space area of over 1000 m2. The building was designed and built with all regulations and standards in the field of transport and distribution of drugs and medical supplies in bulk.
In August 2009 our company received the certificate according to the ISO 9001: 2008 standard. And in July 2018, the recertification of the quality management system according to the standard ISO 9001: 2015 was performed.
Based on the audit which was held between April 15 to April 17 2015 by Agency for Medicine and Medical Devices Unifarm doo has recieved certificate of GDP as first wholesaler in Bosnia and Herzegovina. This certificate is a great achievement of management and all employees of Unifarm and proof that we have progressed and perfected our business.
In the short period of our business Unifarm has developed an enviable distribution network in BiH.
Wide range of products as well as favorable prices and payment conditions have opened the doors of many pharmacies.
Satisfaction with our services is reflected in the steadily increasing interest in co-operation with our enterprise.
As a supplier of pharmacy medicines and medical supplies, Unifarm is directed towards meeting the needs of our customers.
Business success of our clients inevitably leads to our success. To accomplish this we must respond to the set requirements and expand our offerings in all areas, so it is still one of our primary goals of establishing wide cooperation with foreign pharmaceutical companies.